Longevity Biomedical (Longevity Biomedical) EBITDA Margin % : 0.00% (As of . 20)

View and export this data going back to 2050. Start your Free Trial

What is Longevity Biomedical EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Longevity Biomedical's EBITDA for the six months ended in . 20 was $0.00 Mil. Longevity Biomedical's Revenue for the six months ended in . 20 was $0.00 Mil. Therefore, Longevity Biomedical's EBITDA margin for the quarter that ended in . 20 was 0.00%.

Longevity Biomedical EBITDA Margin % Historical Data

The historical data trend for Longevity Biomedical's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Longevity Biomedical EBITDA Margin % Chart

Longevity Biomedical Annual Data

Trend

EBITDA Margin %

Longevity Biomedical Semi-Annual Data

EBITDA Margin %

Competitive Comparison of Longevity Biomedical's EBITDA Margin %

For the Biotechnology subindustry, Longevity Biomedical's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Longevity Biomedical's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Longevity Biomedical's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Longevity Biomedical's EBITDA Margin % falls into.

Longevity Biomedical EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Longevity Biomedical's EBITDA Margin % for the fiscal year that ended in . 20 is calculated as

EBITDA Margin %	=	EBITDA (A: . 20 )	/	Revenue (A: . 20 )
	=		/
	=	%

Longevity Biomedical's EBITDA Margin % for the quarter that ended in . 20 is calculated as

EBITDA Margin %	=	EBITDA (Q: . 20 )	/	Revenue (Q: . 20 )
	=		/
	=	%

Longevity Biomedical (NAS:LBIO) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Longevity Biomedical EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Longevity Biomedical's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Longevity Biomedical (Longevity Biomedical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Longevity Biomedical Inc (NAS:LBIO) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

12100 NE 195th street, Suite 150, Bothell, WA, USA, 98011

Website

https://www.longevitybiomedical.com

Longevity Biomedical Inc is a clinical-stage biomedical company. The company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span. Longevity is acquiring a differentiated therapeutic pipeline of late-stage clinical technologies across ophthalmology, cardiovascular disease, and soft tissue reconstruction and repair.

Longevity Biomedical (Longevity Biomedical) Headlines

No Headlines